SHARE-BASED COMPENSATION (Details) $ / shares in Units, $ in Thousands			12 Months Ended
		Mar. 16, 2023 shares	Oct. 31, 2024 USD ($) Executive $ / shares shares	Oct. 31, 2023 USD ($) $ / shares shares	Oct. 31, 2022 USD ($) $ / shares shares	Mar. 15, 2023 shares
Share-based Compensation [Abstract]
Maximum number of shares of common stock that may be issued (in shares) | shares		5,000,000				4,000,000
Additional shares available for issuance (in shares) | shares		1,000,000
Number of executives departed from company | Executive			2
Expense incurred			$ 13,890	$ 8,001	$ 6,308
Income tax benefits of share-based compensation			1,156	715	449
Cost of Goods Sold [Member]
Share-based Compensation [Abstract]
Expense incurred			2,704	1,259	868
Selling, General and Administrative [Member]
Share-based Compensation [Abstract]
Expense incurred			10,124	5,962	4,803
Research and Development [Member]
Share-based Compensation [Abstract]
Expense incurred			1,062	780	637
Restricted Stock [Member]
Share-based Compensation [Abstract]
Expense incurred	[1]		$ 13,868	$ 7,909	$ 5,800
Shares [Roll Forward]
Outstanding at beginning of period (in shares) | shares			1,238,297	893,704
Granted (in shares) | shares			865,050	791,925	654,224
Vested (in shares) | shares			(550,069)
Cancelled (in shares) | shares			(129,676)
Outstanding at end of period (in shares) | shares			1,423,602	1,238,297	893,704
Expected to vest (in shares) | shares			1,292,883
Weighted-Average Fair Value at Grant Date [Abstract]
Outstanding at beginning of period (in dollars per share) | $ / shares			$ 16.27
Granted (in dollars per share) | $ / shares			29.5	$ 16.84	$ 18.73
Vested (in dollars per share) | $ / shares			17.74
Cancelled (in dollars per share) | $ / shares			21.9
Outstanding at end of period (in dollars per share) | $ / shares			23.23	$ 16.27
Expected to vest (in dollars per share) | $ / shares			$ 23.14
Fair value of awards for which restrictions lapsed			$ 9,755	$ 6,256	$ 5,212
Estimated Expenses Not Yet Incurred [Abstract]
Compensation cost not yet recognized			$ 21,303	$ 12,760	$ 8,949
Weighted-average amortization period (in years)			2 years 9 months 18 days	2 years 9 months 18 days	2 years 8 months 12 days
Restricted Stock [Member] | Minimum [Member]
Share-based Compensation [Abstract]
Award vesting period			1 year
Restricted Stock [Member] | Maximum [Member]
Share-based Compensation [Abstract]
Award vesting period			4 years
Restricted Stock [Member] | Selling, General and Administrative [Member] | Executive [Member]
Share-based Compensation [Abstract]
Expense incurred			$ 1,200
Stock Options [Member]
Share-based Compensation [Abstract]
Expense incurred			0	$ 1	$ 298
Estimated Expenses Not Yet Incurred [Abstract]
Compensation cost not yet recognized			$ 0	$ 0	$ 13
Weighted-average amortization period (in years)					2 months 12 days
Stock Options Activity [Abstract]
Contractual term			10 years
Shares [Roll Forward]
Outstanding at beginning of period (in shares) | shares			472,275
Granted (in shares) | shares			0	0	0
Exercised (in shares) | shares			(191,650)
Cancellations, forfeitures, and adjustments (in shares) | shares			(3,000)
Outstanding at end of period (in shares) | shares			277,625	472,275
Exercisable at end of period (in shares) | shares			277,625
Expected to vest (in shares) | shares			0
Weighted-Average Exercise Price [Abstract]
Outstanding at beginning of period (in dollars per share) | $ / shares			$ 10.18
Granted (in dollars per share) | $ / shares			0
Exercised (in dollars per share) | $ / shares			9.86
Cancellations, forfeitures, and adjustments (in dollars per share) | $ / shares			10.43
Outstanding at end of period (in dollars per share) | $ / shares			10.39	$ 10.18
Exercisable at end of period (in dollars per share) | $ / shares			10.39
Expected to vest (in dollars per share) | $ / shares			$ 0
Weighted-Average Remaining Contractual Life [Abstract]
Outstanding at end of period			1 year 11 months 8 days
Exercisable at end of period			1 year 11 months 8 days
Aggregate Intrinsic Value [Abstract]
Outstanding at end of period			$ 3,445
Exercisable at end of period			3,445
Expected to vest			0
Options Exercised [Abstract]
Total intrinsic value of options exercised			2,981	$ 1,654	$ 5,108
Cash received from options exercises			$ 1,888	1,101	5,275
Stock Options [Member] | Minimum [Member]
Share-based Compensation [Abstract]
Award vesting period			1 year
Stock Options [Member] | Maximum [Member]
Share-based Compensation [Abstract]
Award vesting period			4 years
Employee Stock Purchase Plan [Member]
Share-based Compensation [Abstract]
Maximum number of shares of common stock that may be issued (in shares) | shares			1,850,000
Expense incurred			$ 22	$ 91	$ 210
Award vesting period			1 year
Options Exercised [Abstract]
Percent of market price that participants pay for shares subscribed			85.00%
Total shares issued since inception (in shares) | shares			1,600,000
Unrecognized compensation cost			$ 200

[1] During the year ended October 31, 2024, upon the departure of two executives from the Company and in accordance with the terms of their separation agreements, previously granted time-vesting restricted stock awards accelerated vesting. The Company accounted for the effects of the accelerated vesting of these stock awards as a modification, and recognized $1.2 million of incremental stock-based compensation for the acceleration of restricted stock awards, within selling, general and administrative expenses on the Consolidated Statements of Income for the year ended October 31, 2024.